4GEI
N-terminal domain of VDUP-1
4GEI の概要
| エントリーDOI | 10.2210/pdb4gei/pdb |
| 関連するPDBエントリー | 4GEJ |
| 分子名称 | Thioredoxin-interacting protein (2 entities in total) |
| 機能のキーワード | alpha-arrestin, oxidative stress, metabolism, thioredoxin, protein binding |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Cytoplasm : Q9H3M7 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 17048.43 |
| 構造登録者 | Polekhina, G.,Kok, S.F.,Ascher, D.B.,Waltham, M. (登録日: 2012-08-02, 公開日: 2013-02-27, 最終更新日: 2024-04-03) |
| 主引用文献 | Polekhina, G.,Ascher, D.B.,Kok, S.F.,Beckham, S.,Wilce, M.,Waltham, M. Structure of the N-terminal domain of human thioredoxin-interacting protein. Acta Crystallogr.,Sect.D, 69:333-344, 2013 Cited by PubMed Abstract: Thioredoxin-interacting protein (TXNIP) is one of the six known α-arrestins and has recently received considerable attention owing to its involvement in redox signalling and metabolism. Various stress stimuli such as high glucose, heat shock, UV, H2O2 and mechanical stress among others robustly induce the expression of TXNIP, resulting in the sequestration and inactivation of thioredoxin, which in turn leads to cellular oxidative stress. While TXNIP is the only α-arrestin known to bind thioredoxin, TXNIP and two other α-arrestins, Arrdc4 and Arrdc3, have been implicated in metabolism. Furthermore, owing to its roles in the pathologies of diabetes and cardiovascular disease, TXNIP is considered to be a promising drug target. Based on their amino-acid sequences, TXNIP and the other α-arrestins are remotely related to β-arrestins. Here, the crystal structure of the N-terminal domain of TXNIP is reported. It provides the first structural information on any of the α-arrestins and reveals that although TXNIP adopts a β-arrestin fold as predicted, it is structurally more similar to Vps26 proteins than to β-arrestins, while sharing below 15% pairwise sequence identity with either. PubMed: 23519408DOI: 10.1107/S0907444912047099 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.5 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






